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ABSTRACT
Effects of Acute and Chronic Nicotine Administration on Choice of Probabilistic Outcomes
Katya Nolder
Risky choice can be operationally defined as the choice for a larger, uncertain reinforcer over a
smaller, certain reinforcer. Research suggests smokers engage in more risky or maladaptive
decisions when compared to nonsmokers. The relation between nicotine and risky choice could
benefit from further investigation, since nicotine is the active substance of tobacco products that
maintains tobacco addiction. Acute nicotine administration has shown to alter risky choice;
however, since the everyday smoker uses nicotine repeatedly, more research on chronic
administration is warranted and would allow for assessment of tolerance or sensitization of these
effects. The present study investigated effects of acute and chronic nicotine administration on
risky decision-making in Sprague-Dawley rats using a probability-discounting procedure. The
probability-discounting procedure included discrete-trial choices between a small, certain
reinforcer and a larger, uncertain reinforcer. The probability of larger-reinforcer delivery
systematically decreased across blocks with each session. At baseline, larger-reinforcer choice
systematically declined as a function of decreasing probabilities of delivery, indicating that
choice was sensitive to the programmed contingencies of the procedure. Acute nicotine
administration dose-dependently increased risky choice. Tolerance to nicotine’s effects on
larger-reinforcer choice was observed after repeated 1.0 mg/kg nicotine administration. The
results of the present study add to the existing literature that acute nicotine administration
increases risky choice and demonstrate that tolerance to this effect develops after chronic
exposure to the drug. Possible mechanisms behind this effect are discussed, as are suggestions
for future research on nicotine and risky choice.
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Effects of Acute and Chronic Nicotine Administration on Choice of Probabilistic Outcomes
Nicotine is the active substance of tobacco products that maintains tobacco addiction.
Nearly all tobacco products such as cigarettes, smokeless tobacco, pipe tobacco, cigars, and
hookah contain some amount of nicotine. Tobacco products contain hundreds of harmful
chemicals and repeated tobacco use is the leading cause of preventable disease and death in the
United States (Center for Disease Control and Prevention [CDC], 2018). Repeated tobacco use is
associated with the development of chronic diseases such as lung cancer and coronary heart
disease, and over 16 million Americans live with a disease caused by smoking (CDC, 2018).
While not inherently disease-causing on its own, nicotine sustains tobacco use and dependence
(Markou, 2008).
Though traditional smoking among adults has declined in recent years, e-cigarette use
among youth is prevalent. In 2020, approximately 19.6% of U.S. high school students reported
current use of e-cigarettes, and 23.6% engaged in use of any tobacco product (Gentzke et al.,
2020). Comparatively, only 4.5% of U.S. adults reported current use of e-cigarette products in
2019 (Cornelius et al., 2020). While e-cigarettes do not contain tobacco, the majority of these
products contain nicotine and a variety of potentially toxic chemicals, and the long-term risks of
e-cigarette use is generally unknown (National Institute on Drug Abuse, 2018).
Due to the prevalence of nicotine intake among youth, research on the behavioral effects
of nicotine remains relevant today. Use of nicotine products can have a broad range of
neurobiological and behavioral implications.
Nicotine: Profile and Mechanisms of Action
Nicotine is an alkaloid present in many plants of the nightshade family that acts as a
natural insecticide in tobacco leaves. Nicotine in tobacco largely takes on the levorotatory (S)-
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isomer form (Sobkowiak & Lesicki, 2013). Some ways nicotine enters the human body include
inhalation with tobacco smoke (e.g., traditional cigarettes), inhalation of vapor (e.g., ecigarettes), or absorption through mucous membranes in the mouth (e.g., cigars, smokeless
tobacco). When nicotine is inhaled and absorbed by the lungs, it is quickly moved into the
bloodstream and circulated throughout the brain. When nicotine is absorbed through the mucosa
of the oral cavity, it reaches peak blood and brain levels more slowly. The plasma half-life of
nicotine after cigarette smoking or intravenous infusion averages about 1-2 hours (Benowitz,
2009). When inhaling tobacco smoke, the average smoker takes in approximately 1-2 milligrams
of nicotine per cigarette (National Institute on Drug Abuse, 2020). After this period of absorption
and distribution throughout the body, nicotine is metabolized to cotinine primarily by the enzyme
CYP2A6 (Benowitz, 2010).
Once nicotine is in the brain, it acts as a direct agonist on nicotinic acetylcholine
receptors (nAChRs). These receptors are composed of five subunits, and the α4β2 receptor
subtype is thought to be the main receptor mediating nicotine dependence (Benowitz, 2009).
Acting on these ligand-gated ion channels results in cell depolarization and excitation, which
facilitates the downstream release of many neurotransmitters, including acetylcholine, dopamine
(DA), glutamate, γ-aminobutyric acid, and serotonin (Benowitz, 2009; Markou, 2008).
Nicotine-mediated activation of the ventral tegmental area within the mesolimbic
pathway increases DA levels in the nucleus accumbens (Benowitz, 2009; Mansvelder &
McGehee, 2002; Markou, 2008; Ohmura et al., 2012). This interaction with the mesolimbic
pathway is likely responsible for nicotine’s rewarding and reinforcing effects (Corrigall et al.,
1992). Nicotine also activates the sympathetic nervous system and releases epinephrine and
norepinephrine into the bloodstream (Jadzic et al., 2021). General psychoactive effects of
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nicotine exposure can include mood regulation, reduced anxiety, heightened concentration,
increased heart rate, and improved performance on certain tasks, and this profile seems to
indicate nicotine borders between both stimulant and sedative drug classes (Benowitz, 2009;
Heishman et al., 2010; Markou, 2008; Parrott, 1998). For example, preclinical models using the
elevated-plus maze paradigm found nicotine exerted anxiolytic effects (i.e., increased time in the
open arms) in adolescent male rats, but exerted anxiogenic effects (i.e., decreased time in the
open arms) in female rats and adult male rats (Elliott et al., 2004). Nicotine use is associated with
positive effects on working memory, response time, attention, and other skills in smokers
(Heishman et al., 2010), and other research suggests smokers may use the nicotine in tobacco
products to help with mood and emotion regulation (see Picciotto et al., 2015 for a review).
Finally, withdrawal after repeated nicotine use is associated with aversive symptoms such
as increased irritability, depressed mood, and difficulty concentrating (Benowitz, 2009; 2010).
Avoidance of the aversive components of drug withdrawal may also function in the maintenance
of nicotine dependence (i.e., negative reinforcement). Rats readily acquire nicotine selfadministration (e.g., Feltenstein et al., 2012; Flores et al., 2019), suggesting its everyday abuse
potential, and nicotine can fully substitute for cocaine in certain drug-discrimination paradigms,
likely due to nicotine-induced DA release (e.g., Desai et al., 2003). Cocaine does not seem to
substitute for nicotine in drug-discrimination paradigms though, supporting the view that the
nicotine cue is facilitated primarily through central cholinergic mechanisms (e.g., Desai et al.,
2003; Stolerman et al., 1984).
Nicotine and Impulsive Choice
There is evidence that nicotine influences impulsive choice, as demonstrated by delaydiscounting procedures (Anderson & Diller, 2010; Dallery & Locey, 2005; Íbias & Nazarian,
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2020; Kayir et al., 2014; Kolokotroni et al., 2011; Ozga & Anderson, 2018). Impulsive choice is
operationally defined as the choice for a small, immediate reinforcer, over a larger, delayed
reinforcer. Impulsive choice can be assessed through a delay-discounting procedure using the
within-session format first described by Evenden and Ryan (1996). This delay-discounting
procedure involves discrete-trial choices between a smaller, more immediate reinforcer and a
larger, delayed reinforcer, with the delay increasing in predetermined intervals across an
experimental session. Using this within-session procedure, acute nicotine administration
increased choice of the larger-later reinforcer (i.e., decreased impulsive choice) in both Lewis
(LEW) and Fischer 344 (F344) rats (Anderson & Diller, 2010). In another study, acute doses of
nicotine again reduced delay discounting (i.e., decreased impulsive choice) in both LEW and
F344 rats, and AChR antagonists, mecamylamine and scopolamine, attenuated these effects of
nicotine on delay discounting (Ozga & Anderson, 2018). However, some preclinical research
suggests nicotine exposure may increase impulsive choice (Kolokotroni et al., 2011), though this
may be a sex-dependent effect (Íbias & Nazarian, 2020), or dependent on baseline choice rates
(Kayir et al., 2014; Kolokotroni et al., 2014). Additionally, Dallery and Locey (2005) tested five
Long-Evans rats using an adjusting-delay procedure, and under this paradigm acute and chronic
nicotine administration decreased choice of the larger-later reinforcer (i.e., increased
impulsivity).
Within human samples, there is research indicating smokers make significantly more
impulsive choices when compared to nonsmokers on delay-discounting procedures, whether the
situations involve monetary outcomes, cigarette rewards, health outcomes, and other
commodities such as alcohol and food (see Barlow et al., 2016 for a review). However, the
majority of choices provided in human delay-discounting procedures are hypothetical, and
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resulting discounting rates of real or potentially real rewards during experimental sessions have
conflicted with discounting rates under hypothetical conditions (Green & Lawyer, 2014;
Robertson & Rasmussen, 2018), particularly in certain populations such as children (Miller,
2019), and individuals with schizophrenia (Horan et al., 2017)
When studying impulsive choice, effects of delay to gratification (i.e., delay discounting)
are typically assessed, but changes in motor inhibition and attentional performance can also be
evaluated through procedures such as the five-choice serial reaction time task (5-CSRTT) or
go/no-go tasks (Ohmura et al., 2012). Premature responses during interresponse times between
trials on these tasks is regarded as a failure of inhibitory control, or increased impulsivity. Across
multiple experiments, nicotine increased premature responding during these interresponse
periods on the 5-CSRTT (Blondel et al., 1999; Higgins et al., 2020; Semenova et al., 2007;
Stolerman et al., 2009) and go/no-go tasks (Higgins et al., 2020; Kolokotroni et al., 2011; 2012).
In conclusion, it seems cholinergic systems are involved in impulsivity, and while more
research on these effects is warranted, there is evidence that smokers frequently engage in other
types of maladaptive decision-making, particularly risky choice, which is studied through
different decision-making paradigms.
Risky Decision-Making
Risky choice is the choice for an option associated with some probability of either a
reinforcing or aversive consequence. Examples of common types of risky behavior include
gambling, unprotected sexual activity, drug use, and dangerous driving (Chuang et al., 2017; Dir
et al., 2014; Hayashi et al., 2019). Risky decision-making is characteristic of multiple psychiatric
and behavioral disorders including substance abuse (e.g., Barry & Petry, 2008; Kjome et al.,
2010; Petry et al., 1998; Whitlow et al., 2004), schizophrenia (e.g., Pedersen et al., 2017; Struglia
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et al., 2011), pathological gambling (see Kyonka & Schutte, 2018 for a review), attentiondeficit/hyperactivity disorder (see Dekkers et al., 2016 for a review), and obesity (see Rotge et
al., 2017 for a review).
Within basic research, a variety of procedures to assess risky choice are available
including the risky decision-making task (e.g., Mitchell et al., 2011; Simon et al., 2009; Simon &
Setlow, 2012), rat gambling task (e.g., Silveira et al., 2015; Spoelder et al., 2015; Zeeb et al.,
2009), and probability-discounting procedure (e.g., Cardinal & Howes, 2005; Jenni et al., 2017;
Mendez et al., 2010; St. Onge & Floresco, 2009; Wallin et al., 2015). The risky decision-making
task assesses choice for a small, safe reinforcer over a large, risky reinforcer that is associated
with differing probabilities of punishment, such as a 1-s footshock (see Simon et al., 2009;
Simon & Setlow, 2012). In the rat gambling task four apertures are illuminated, each associated
with a different schedule of reinforcement/punishment and reinforcer magnitude. It is optimal to
choose the less risky options to maximize earnings (see Zeeb et al., 2009 for a review of the
procedure).
The probability-discounting procedure involves discrete-trial choices between a small,
certain reinforcer and a larger, uncertain reinforcer. The larger reinforcer is associated with
varying probabilities of delivery, and the probability of larger-reinforcer delivery is manipulated
across a session. Generally, when the probability of larger-reinforcer delivery is high, choice will
lean exclusively towards the larger outcome, and as this probability decreases, choice switches
over to the smaller, certain option. Probability-discounting procedures share some features with
delay-discounting procedures, and comparison of drug effects along these paradigms is an
ongoing area of research (see Green & Myerson, 2013).
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There is evidence that impulsive choice and risky decision-making are distinct processes
(Green & Myerson, 2004; 2013; Takahashi, 2006). Structurally distinct regions of the medial and
orbital prefrontal cortex differentially affect these separate types of decision-making (Floresco et
al., 2008). Additionally, pharmacological manipulations can have different effects on largerreinforcer choice depending on the type of choice procedure. For example, it is well documented
that psychostimulants such as amphetamine and methylphenidate generally decrease impulsive
choice on delay-discounting procedures (e.g., Huskinson et al., 2012; Krebs & Anderson, 2012;
Wade et al., 2000; Winstanley et al., 2003), but other evidence suggests psychostimulants may
increase risky decision-making on probability-discounting and rat gambling tasks (e.g.,
Baarendse et al., 2013; Floresco & Whelan, 2009; Ozga-Hess & Anderson, 2019; St. Onge et al.,
2010; Zeeb et al., 2009). Due to the prevalent therapeutic use of psychostimulants, it is important
to understand the full behavioral profile of these drugs. The procedural similarities between
delay-discounting and probability-discounting procedures can lend to more direct comparisons of
pharmacological manipulations.
Discounting of probabilistic outcomes can be described by a hyperbolic function (e.g.,
Green & Myerson, 2004; 2013). Indifference points (IPs), the point at which the two reinforcers
are of equal subjective value (i.e., choice for either reinforcer would happen 50% of the time),
are used to plot discount curves. Probability discounting is described mathematically as,
𝑉=

𝐴
.
(1 + ℎΘ)

(1)

In this equation, V is the subjective value of the larger, uncertain reinforcer at an amount
of A (reinforcer magnitude), and h is a free parameter that represents rate of probability
discounting. Θ is odds against receipt of the reinforcer, calculated as (1-p)/p, where p is the
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probability of receiving the larger reinforcer. Subjective value of the larger reinforcer is plotted
as a function of the odds against its receipt.
The primary dependent variable of interest within the probability-discounting procedure
is percent larger-reinforcer choice, an index commonly used when some parameter associated
with the larger reinforcer systematically shifts within a single session (e.g., Bari et al., 2010;
Jenni et al., 2017; Larkin et al., 2016; Stopper et al., 2014). Generally, probability of largerreinforcer delivery decreases across blocks of a session (i.e., odds against larger-reinforcer
delivery increases). Percent larger-reinforcer choice is plotted as a function of the probability of
larger-reinforcer delivery and estimates of IPs and h are interpolated from model fits of percent
larger-reinforcer choice. Using this paradigm, higher IPs indicate more larger-reinforcer choices.
Smaller h values characterize shallow probability-discounting functions and indicate higher
levels of risky choice. Another measure derived from the discounting function is area under the
curve (AUC). Larger AUC implies more risky choice.
Other dependent variables within probability discounting are win-stay and lose-shift
ratios (e.g., Bari et al., 2010; Jenni et al., 2017; Larkin et al., 2016; Stopper et al., 2014). To
calculate these measures, choice for individual trials are evaluated against the choice and
outcome of each preceding trial, particularly when the preceding trial involved choice for the
larger, uncertain reinforcer. Choice for the larger, uncertain reinforcer on the preceding trial of
interest is categorized as a “win” if choice resulted in larger-reinforcer delivery, or a “loss” if
choice did not result in larger-reinforcer delivery. Win-stay ratios are expressed as the number of
choices for the larger, uncertain reinforcer following a “win” on the preceding trial, divided by
the total number of trials that resulted in a “win” on the larger, uncertain alternative. Lose-shift
ratios are expressed as the number of choices for the smaller, certain reinforcer following a
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“loss” on the preceding trial, divided by the total number of trials that resulted in a “loss” on the
larger, uncertain alternative. Ratio calculations allow for evaluation of reinforcer sensitivity (i.e.,
win-stay) and loss aversion (i.e., lose-shift). Larger win-stay ratios indicate higher reinforcer
sensitivity while larger lose-shift ratios indicate higher loss aversion.
Nicotine and Risky Decision-Making
Research indicates that smokers are more likely to engage in problem gambling than
nonsmokers (e.g., McGrath & Barrett, 2009; McGrath et al., 2012). Smoking status is also
associated with increased risk of injury, and smokers are more likely to be involved in motor
vehicle accidents, falls, fires, and job-related injuries compared to their nonsmoker counterparts
(e.g., Wen et al., 2005). Additionally, risky decision-making is characteristic of behavioral
disorders such as chronic substance abuse (e.g., Barry & Petry, 2008; Kjome et al., 2010; Petry et
al., 1998; Whitlow et al., 2004). These effects suggest smokers may be engaging in more risky or
maladaptive decisions when compared to nonsmokers. However, it is not clear if these
individuals are making more risky choices due to a history of substance abuse and exposure to
nicotine, or some other factor (e.g., behavioral history, genetics, neurochemistry). The use of
animal models in discounting research allows for control of extraneous variables and systematic
evaluation of drug effects on choice to answer these types of questions.
In contrast to research on cholinergic systems, there is extensive basic research on
dopaminergic contributions to risky choice. Multiple studies suggest DA receptors mediate
choice on the rat gambling task through interactions with various neurotransmitter systems (see
Di Ciano & Le Foll, 2018 for a review). Specifically, heightened activation of D1 and D2
receptors may increase risky choice, while activation of D3 receptors may decrease risky choice
(e.g., St. Onge & Floresco, 2009). Administration of amphetamine, a DA agonist, is associated
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with increased suboptimal decision-making on the rat gambling task and increased choice for the
larger, uncertain reinforcer on probability-discounting procedures (e.g., Di Ciano & Le Foll,
2018; Jenni et al., 2017; St. Onge & Floresco, 2009). Since nicotine interacts with dopaminergic
neurons and can have stimulant-like properties, nicotine may have similar effects on risky-choice
procedures.
Some risky-choice paradigms have been used to assess direct effects of nicotine on
decision-making in animal models. Acute 0.6 mg/kg nicotine decreased choice for the large,
risky option in Long-Evans rats on a risky decision-making procedure, suggesting increasing
doses of nicotine may be associated with more risk-averse choice (Mitchell et al., 2011). Under a
probabilistic delay-discounting task, in which both delay and probability of reinforcer delivery
were manipulated (one choice was immediate and not certain, while the other choice was certain
but delayed), and reinforcer magnitude was equivalent across choices, acute 1.2 mg/kg nicotine
increased choice for the immediate, but less certain option (Kelsey & Niraula, 2012). Neither of
these procedures are direct probability-discounting assessments but can help elucidate nicotine’s
effects on all facets of risky decision-making. It seems nicotine may modify or increase the
aversiveness of certain punishing stimuli (e.g., shock), and when delay and probability
discounting interact during nicotine exposure, this may cause a synergistic increase in
maladaptive decision-making. Additionally, higher levels of nAChRs binding was significantly
associated with less risky choice in a probability-discounting task, indicating cholinergic systems
are involved in risky decision-making (Mendez et al., 2013). Administration of nicotine had no
significant effects on choice in the rat gambling task, but the highest dose the researchers used to
test this effect was 0.4 mg/kg nicotine (Silveira et al., 2015).
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To date, only one study has published effects of nicotine on a within-session probabilitydiscounting procedure using an animal model. Mendez et al. (2012) demonstrated acute 1.0
mg/kg nicotine administration increased choice for the larger, uncertain reinforcer (i.e., increased
risky decision-making relative to saline vehicle levels) in Long-Evans rats. Future research could
replicate acute procedures, as well as investigate repeated (chronic) effects of nicotine on
probability discounting. Compared to acute administration of nicotine, chronic administration
better simulates the level of nicotine exposure experienced by a habitual smoker (e.g., Benowitz,
2009; 2010).
Nicotine and Tolerance
Repeated exposure to drugs of abuse may have differing effects on behavior, when
compared to acute effects. Tolerance or sensitization may result from chronic administration of a
drug (see Branch, 1993; Stewart & Badiani, 1993). If a drug’s effects diminish with repeated
administration, tolerance has developed, illustrated by a rightward shift in the dose-effect curve.
Larger doses of that drug would be required to produce the initial observed effect. Sensitization
has developed if a drug’s effects are enhanced following repeated exposure, characterized by a
leftward shift in the dose-effect curve.
Both the development of tolerance and sensitization have been demonstrated with
repeated administration of nicotine, and these effects are likely dependent on factors such as
dose, behavioral task, strain, sex, and age. For example, in a delay-discounting task, acute
administration of nicotine decreased impulsive choice, and repeated 1.0 mg/kg nicotine resulted
in a return to baseline levels of choice in LEW and F344 rats (i.e., tolerance; Anderson & Diller,
2010). In another study, acute nicotine administration had no systematic effects on impulsive
choice, and chronic nicotine exposure increased impulsive choice in Wistar rats, but this effect
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was dependent on baseline rates of choice (Kayir et al., 2014). Using an adjusting-delay
procedure, Dallery and Locey (2005) found that chronic 0.3 and 1.0 mg/kg nicotine increased
impulsive choice relative to acute administration in Long-Evans rats, and high impulsive choice
levels continued for at least a month after nicotine cessation (i.e., sensitization). Repeated
administration of nicotine has also showed mixed results on premature responding in the 5CSRTT (Blondel et al., 1999; Semenova et al., 2007).
Statement of the Problem
Nicotine maintains tobacco addiction, and nicotine use is prevalent among youth. The
relation between nicotine and risky choice could benefit from further investigation, considering
risky decision-making is characteristic of substance abuse and multiple other behavioral
disorders. Compared to other neurotransmitter systems, there is less research investigating
cholinergic effects on risky choice. Acute nicotine administration has shown to alter risky
choice; however, since the everyday smoker uses nicotine repeatedly, more research on chronic
administration is warranted and would allow for assessment of tolerance or sensitization of these
effects. The current project investigated effects of acute and chronic nicotine administration on
risky decision-making through a probability-discounting procedure.
Method
Subjects
Eight male Sprague-Dawley rats, all experimentally naïve, served as subjects. One rat
died prematurely after the acute baseline phase, so the remaining phases were conducted with
seven rats. Rats were pair-housed in controlled environmental conditions (temperature, 24 °C;
12-h reverse light/dark cycle), with continuous access to water. Rats were fed 30 min following
each experimental session, allowing for approximately 22 h of food restriction. Sessions were
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conducted at approximately the same time each day. Sessions were conducted five days of the
week (Monday-Friday) during training, baseline, and acute drug administration, and seven days
of the week during chronic drug administration and redetermination of the dose-effect curve.
Apparatus
Experimental sessions were conducted in eight standard operant-conditioning chambers
for rats, each enclosed in a melamine sound-attenuating cubicle (Med Associates, VT). Each
chamber contained a working area of 30.5 cm by 24.5 cm by 21.0 cm, a grid floor, and a 45-mg
pellet dispenser with a pellet receptacle that was centered between two retractable response
levers. The levers were 11.5 cm apart from each other and required a force of 0.25 N for a
response to be recorded. The levers were 4.8 cm wide, elevated 8 cm from the grid floor, and
protruded 1.9 cm into the chamber. Two 28-V stimulus lights, 2.5 cm in diameter, were located 7
cm above each lever. Each chamber contained a 28-V houselight on the wall opposite the wall
containing the operanda. A ventilation fan circulated air and masked extraneous noise. Data
collection and programmed consequences were controlled by a personal computer equipped with
Med-PCTM software (Med Associates, VT).
Procedure
Probability-Training Procedure
After lever-pressing was established, sessions consisted of an alternating fixed-ratio (FR)
1 schedule of reinforcement, in which only one lever extended into the chamber at a time, with a
cue light illuminated above it. A press on the available lever resulted in the delivery of one food
pellet. The FR 1 contingency and cue light alternated between the two levers after every five
food-pellet deliveries. Alternating FR 1 sessions terminated once 40 food pellets had been
delivered.
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After lever-pressing was consistent on both levers, a probability-training procedure went
into effect to expose behavior to the probabilistic nature of the full task (procedure similar to
Ozga-Hess & Anderson, 2019). Each session consisted of 90 trials (45 trials per lever) and each
trial began every 40 s. During each trial, one lever extended into the chamber with the cue light
above it illuminated. In every pair of trials, the left or right lever was presented once, and the
order of lever presentation within the pair of trials was random. A response on that lever resulted
in the delivery of one food pellet with 50% probability of delivery. If responding occurred within
10 s of the trial onset, the lever retracted, cue light turned off, and the remaining intertrial
interval (ITI) began. If a response did not occur within 10 s of the onset of a trial, the lever
retracted, the houselight and cue light turned off, and an omission was recorded. The probabilitytraining procedure was in effect for at least five sessions with a criterion of fewer than 10
omitted trials for three consecutive sessions.
Probability-Discounting Procedure
After probability training was complete, the probability-discounting procedure was in
effect for the remainder of the study (similar to procedures used by Jenni et al., 2017; Larkin et
al., 2016; Ozga-Hess & Anderson, 2019; Stopper & Floresco, 2011). During the probabilitydiscounting procedure, one lever was associated with one food pellet with 100% likelihood of
delivery and the other lever was associated with three food pellets with varying probabilities of
delivery. The position of the lever associated with each reinforcer was counterbalanced across
rats and remained constant throughout the study.
All probability-discounting sessions began with a 10-min blackout period. Each session
consisted of five blocks of 24 trials each. The start of each block was signaled by five 0.5-s
flashes of the houselight, followed by 16 forced-choice trials. In forced-choice trials, a single,
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randomly determined lever was inserted into the chamber and a cue light was illuminated above
the lever. After one response on the extended lever, one food pellet was delivered, or three food
pellets with varying probabilities of delivery (100%, 50%, 25%, 12.5%, or 6.25%) were
delivered. The houselight flashed for 0.1 s as each food pellet was delivered. After delivery, the
lever retracted, cue lights turned off, and a 20-s ITI began. Forced-choice trials were presented
quasi-randomly such that a given lever would be presented on no more than two consecutive
trials unless the other lever had already been presented eight times in each block of forced-choice
trials. Probability of larger-reinforcer delivery during forced-choice trials was dependent on
outcomes across the forced-choice trials. To elaborate, during the 100% probability block,
responding on any of the eight larger, uncertain lever presentations always lead to largerreinforcer delivery, and during the 50%, 25% and 12.5% probability blocks, reinforcement was
only available on four trials, two trials, or one of the eight forced-choice trials, respectively.
Forced-choice trials during the 6.25% probability block for the larger, uncertain lever
were sampled from a distribution that produced the large, uncertain reinforcer every one out of
16 responses, on average. Therefore, responses on the forced-choice trials produced the large,
uncertain reinforcer during this final block approximately once every two sessions. The forcedchoice trials served to fully expose choice to the reinforcer probabilities for that block.
Forced-choice trials were followed by eight free-choice trials, during which both levers
extended into the chamber, with cue lights illuminated over each, and choice between the
smaller, certain reinforcer and larger, uncertain reinforcer was recorded. After one response on
either lever, cue lights turned off, levers retracted, and food pellets were delivered. The
houselight flashed for 0.1 s as each food pellet was delivered. The probability of larger-reinforcer
delivery was independent during free-choice trials (i.e., the probability of larger-reinforcer
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delivery on any given trial was the same regardless of the outcome on preceding trials). The
probability of larger-reinforcer delivery systematically decreased across blocks of trials.
For both forced-choice and free-choice trials, if a response did not occur within 10 s of a
trial onset, an omission was recorded. After an omission, the lever(s) retracted, the houselight
and cue light(s) turned off, and a 20-s ITI began. Termination of sessions resulted after 120 total
trials (80 forced-choice and 40 free-choice), or 70 min, whichever occurred first.
Baseline Assessment. Baseline probability discounting for each rat was assessed by
varying larger-reinforcer probability across blocks. The probability of larger-reinforcer delivery
systematically decreased across blocks of trials (corresponding to probabilities of 100%, 50%,
25%, 12.5%, and 6.25%). Rats were tested in the probability-discounting task for a minimum of
20 sessions before drug administration and continued the task until stable performance was
achieved across five consecutive sessions. Stability was determined through visual inspection
and two-way analysis of variance (ANOVA). Stability was marked by an average equal to or
greater than 80% choice for the larger reinforcer during the first probability block of a session
(i.e., the 100% probability block), the presence of a main effect of trial block, and the absence of
a main effect of session, as well as the absence of an interaction between session and trial block.
Acute Nicotine Administration. After stable baseline probability discounting was
established for individual rats, acute effects of nicotine were evaluated. Subcutaneous injections
of nicotine and the vehicle control, saline, were administered on Tuesdays and Fridays of each
week, given stability criteria were met the previous session. Behavior was considered stable if
larger-reinforcer choice was equal to or greater than 80% choice during the first probability
block and if the overall percent larger-reinforcer choice was within the range of stable baseline
performance. Mondays and Thursdays served as non-drug control sessions. All injections took
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place immediately before sessions in 0.0, 0.1, 0.3, and 1.0 mg/kg doses (e.g., Anderson & Diller,
2010; Ozga & Anderson, 2018). Saline was administered in at least two sessions prior to any
drug exposure, to decrease any behavioral disruption due to injection procedures (i.e., allow for
habituation). Doses were administered in ascending order, with each dose administered at least
twice.
Chronic Nicotine Administration. Following acute drug administration, nicotine was
administered daily, and sessions were conducted seven days of the week. 1.0 mg/kg nicotine was
selected as the chronic dose since it was the highest dose that affected percent larger-reinforcer
choice during acute administration (e.g., Huskinson et al., 2012; Slezak & Anderson, 2011). 1.0
mg/kg nicotine was administered prior to each experimental session for a minimum of 30
sessions. Once stable performance was achieved across five consecutive sessions (see the
stability markers for baseline assessment), the dose-effect function was redetermined. During
redetermination of dose-effect functions, effects of each dose previously tested were reassessed
at least twice on Tuesdays and Fridays (given stability criteria were met the previous session; see
stability markers for acute administration), with the repeated dose administered before all other
sessions. All injections took place immediately before sessions in 0.0, 0.1, 0.3, 1.0, and 1.7
mg/kg doses.
Due to complications from the COVID-19 pandemic, laboratory research was suspended
during the beginning of chronic 1.0 mg/kg nicotine administration. During this period, daily 1.0
mg/kg nicotine administrations continued, but no behavioral sessions were conducted (a total of
74 days). Once COVID-19 shutdown restrictions were lifted, experimental sessions resumed, and
chronic baselines were reestablished. Some test dose data points during this chronic
redetermination phase were discarded if stability was not met within the previous session. These

NICOTINE AND CHOICE OF PROBABILISTIC OUTCOMES

18

test doses were incorrectly administered due to experimenter error. The chronic redetermination
analyses only include test doses that followed stable performance. These analyses still include
the minimum of two tests per dose for each rat.
Drugs
Nicotine hydrogen tartrate was purchased from Sigma-Aldrich (St. Louis, MO). Each
dose of nicotine was dissolved in 0.9% sodium-chloride solution (saline vehicle) at a
concentration of 1.0 mg/ml and delivered in a volume of 1.0 ml/kg subcutaneously. Dosing and
preparation procedures were adapted from previous research with nicotine and operant behavior
in rats (e.g., Anderson & Diller, 2010; Ozga & Anderson, 2018).
Data Analysis
Dependent Measures
Percent Larger-Reinforcer Choice. The primary dependent variable was percent largerreinforcer choice. This measure was calculated by dividing the number of free-choice responses
on the lever associated with the uncertain reinforcer by the total amount of free-choice responses
made per session block. Percent larger-reinforcer choice was plotted as a function of the
decreasing probabilities of larger-reinforcer delivery. In terms of maximizing earnings during a
session, choice for the larger, uncertain reinforcer was advantageous in the first two session
blocks, and disadvantageous in the last three blocks (e.g., Adriani & Laviola; 2006; Larkin et al.,
2016; St. Onge et al., 2012). Steeper functions indicate less risky choice, while shallow functions
indicate more risky choice.
Percent Larger-Reinforcer Choice Last Three Blocks. An additional analysis of
percent larger-reinforcer choice was conducted by assessing responses made in the last three
blocks of a session (i.e., when larger-reinforcer choice was maladaptive). This was done by
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dividing the number of free-choice responses for the uncertain reinforcer in the last three blocks
of a session by 24 (the total amount of free-choice responses that could be made during the last
three blocks), and calculating this number as a percentage.
Discounting Rate (h) and Indifference Points (IPs). Estimates of h and IPs were
interpolated from model fits of percent larger-reinforcer choice based on the hyperbolic formula
developed by Mazur for delay discounting (1987; see Equation 1). Mean percent largerreinforcer choice during the first probability block was used an estimate of the A parameter. IPs
were transformed to reflect indifference to probability of larger-reinforcer delivery (as opposed
to odds against reinforcer delivery), so lower IPs are associated with more risky choice. Smaller
h values indicate higher levels of risky choice.
Area Under the Curve (AUC). AUC was calculated for discounting rates based on the
formula described by Myerson et al. (2001). AUC calculation involves drawing vertical lines
from each data point of the discounting curve to the x-axis (i.e., probability of larger-reinforcer
delivery), which subdivides the graph into a series of trapezoids. AUC is equal to the sum of the
trapezoid areas and expresses the proportion of larger-reinforcer responding. AUCs can range
from 0.0 (exclusive choice for the smaller, certain reinforcer) to 1.0 (exclusive choice for the
larger, uncertain reinforcer). Larger AUC implies more risky choice.
Win-Stay/Lose-Shift Ratios. Individual trials within each session were evaluated against
the choice and outcome of each preceding trial, particularly when the preceding trial involved
choice for the larger, uncertain reinforcer (see Bari et al., 2010; Jenni et al., 2017; Larkin et al.,
2016; Stopper et al., 2014). Win-stay trials were calculated by dividing the number of choices for
the larger, uncertain reinforcer following a “win” by the total number of free-choice trials that
resulted in reinforcement on the larger, uncertain outcome. Lose-shift trials were calculated by
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dividing the number of choices for the smaller, certain reinforcer following a “loss” by the total
number of free-choice trials that resulted in a “loss” on the larger, uncertain outcome. Larger
win-stay ratios indicate higher reinforcer sensitivity while larger lose-shift ratios indicate higher
loss aversion.
Omitted Free-Choice Trials. Omitted free-choice trials were analyzed as a secondary
measure. An omission was recorded if a response did not occur within 10 s of the trial onset.
Statistical Analyses
Three-way repeated-measures analysis of variance (ANOVA) were conducted to analyze
effects of session block, drug dose, and condition on percent larger-reinforcer choice. Two-way
repeated-measures ANOVA were used to examine effects of drug dose and condition on percent
larger-reinforcer choice last three blocks, h estimates, IPs, AUC, win-stay ratios, and lose-shift
ratios. Greenhouse-Geisser (1959) corrections were used to adjust for violations of the sphericity
assumption as needed, depending on epsilon values. For significant main effects and/or
interactions, pairwise comparisons were conducted. For all analyses, statistical significance was
defined as p < .05.
Results
The general statistical results for all primary outcome measures are reported in Table 1.
Pairwise comparison tests showed no significant differences between saline vehicle and baseline
(control) levels on any of the primary dependent variables.
Baseline
Figure 1 displays the mean percent larger-reinforcer choice as a function of probability of
delivery during the last five sessions of baseline for all rats (N = 8). Larger-reinforcer choice
systematically declined as a function of decreasing probabilities of delivery, indicating that
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choice was sensitive to the programmed contingencies of the procedure [F(4) = 105.917, p <
.001]. Table 2 shows the mean percent-larger reinforcer choice for each rat during the last five
sessions of baseline.
Acute Percent Larger-Reinforcer Choice
Note that all analyses after the acute baseline phase were conducted with seven rats (N = 7).
Figures 2 and 3 show percent larger-reinforcer choice as a function of probability of delivery for
group and individual means, respectively. Similar to baseline responding, larger-reinforcer
choice decreased as a function of probability of delivery [F(2.009) = 119.064, p < .001]. There
was a main effect of dose on percent larger-reinforcer choice [F(3) = 7.732, p = 0.002] and a
significant dose x block interaction was observed [F(2.632) = 6.618, p = .007].
Pairwise comparisons indicated that nicotine significantly increased percent largerreinforcer choice primarily in the fourth block. At the 0.3 mg/kg dose, percent larger-reinforcer
choice was significantly higher in the fourth block [t(6) = -3.655, p = .011], relative to saline. At
the 1.0 mg/kg dose, percent larger-reinforcer choice was significantly higher in the fourth block
[t(6) = -5.867 , p = .001] and the fifth block [t(6) = -5.867, p = .023], relative to saline. Higher
levels of percent larger-reinforcer choice indicate more risky choice. See Table 3 for means and
standard error of the mean (SEM) for percent larger-reinforcer choice during each block at each
dose.
Acute Omissions
There was no significant effect of dose on the frequency of omitted trials during acute
drug exposure [F(3) = 1.613, p = 0.221]. See Table 7 for omissions at each dose for individual
rats.
Chronic Nicotine Exposure
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Figure 4 displays mean AUC for saline and 1.0 mg/kg nicotine during acute drug exposure,
and the first five days of chronic 1.0 mg/kg nicotine exposure. Pairwise comparisons revealed
AUC was significantly lower at Day 3 [t(6) = 2.584, p = .042] and Day 5 levels [t(6) = 4.424, p =
.004] compared to acute 1.0 mg/kg nicotine administration. Additionally, AUC at Day 1 was
significantly higher than Day 4 [t(6) = 2.836, p = .030] and Day 5 values [t(6) = 2.870, p = .028].
These differences indicate that habituation to nicotine’s effects on risky choice happened
relatively quickly, since AUC subsided to near-baseline levels by Day 5 of chronic 1.0 mg/kg
nicotine exposure. Larger AUC levels indicate more risky choice. See Table 4 for AUC levels
for individual rats.
Chronic Percent Larger-Reinforcer Choice
Note, there were no significant differences between acute and chronic saline levels on
percent larger-reinforcer choice (see Figure 12). Figure 5 shows mean percent larger-reinforcer
choice as a function of probability of delivery during the re-administration of test doses
following chronic 1.0 mg/kg nicotine exposure. Figure 6 shows percent larger-reinforcer choice
as a function of probability of delivery during this re-administration for individual means. During
the chronic phase there was a main effect of block [F(1.894) = 216.180, p < .001] and a main
effect of dose [F(4) = 4.943, p = 0.005] on percent larger-reinforcer choice.
Pairwise comparisons indicated that 1.7 mg/kg nicotine significantly increased percent
larger-reinforcer choice in the third block [t(6) = -3.151, p = .020] and fourth block [t(6) = 3.722, p = .010], relative to saline. Higher levels of percent larger-reinforcer choice indicate
more risky choice. See Table 5 for means and SEM for percent larger-reinforcer choice during
each block at each dose.
Chronic Omissions

NICOTINE AND CHOICE OF PROBABILISTIC OUTCOMES

23

There was no significant effect of dose on the frequency of omitted trials during chronic
drug exposure [F(4) = 1.340, p = 0.284]. See Table 7 for omissions at each dose for individual
rats.
Acute and Chronic Comparisons
Percent Larger-Reinforcer Choice Across the Last Three Blocks
Figure 7 shows mean percent larger-reinforcer choice across the last three blocks as a
function of each dose of nicotine during acute and chronic drug exposure. There was a
significant effect of dose during the acute condition [F(3) = 14.201, p < .001] and a significant
effect of dose during the chronic condition [F(4) = 5.167, p = 0.004]. There was a significant
effect of condition when comparing the acute and chronic values [F(1) = 6.923, p = 0.039], and a
significant condition x dose interaction [F(3) = 4.161, p = 0.021].
Pairwise comparisons indicated that 0.3 mg/kg nicotine significantly increased percent
larger-reinforcer choice [t(6) = -4.147, p = 0.006] and 1.0 mg/kg nicotine significantly increased
percent-larger reinforcer choice [t(6) = -4.371, p = .005], relative to saline during the acute
condition. Only 1.7 mg/kg nicotine significantly increased percent larger-reinforcer choice [t(6)
= -5.212, p = 0.002], relative to saline during the chronic condition. Higher levels of percent
larger-reinforcer choice indicate more risky choice. See Table 6 for percent larger-reinforcer
choice during the last three blocks at each dose and condition for individual rats.
Area Under the Curve (AUC)
Figure 8 shows mean AUC as a function of each dose of nicotine during acute and
chronic drug exposure. There was a significant effect of dose during the acute condition [F(3) =
13.494, p < .001] and a significant effect of dose during the chronic condition [F(4) = 6.613, p =
0.001]. There was a significant condition x dose interaction [F(3) = 5.582, p = 0.007].
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Pairwise comparisons indicated that 0.3 mg/kg nicotine significantly increased AUC [t(6)
= -3.764, p = 0.009] and 1.0 mg/kg nicotine significantly increased AUC [t(6) = -4.389, p
=0.005], relative to saline during the acute condition. Only 1.7 mg/kg nicotine significantly
increased AUC [t(6) = -4.789, p = 0.003], relative to saline during the chronic condition. Larger
AUC levels indicate more risky choice. See Table 6 for AUC levels at each dose and condition
for individual rats.
Indifference Points (IPs)
Figure 9 shows mean IPs as a function of each dose of nicotine during acute and chronic
drug exposure. There was a significant effect of dose during the acute condition [F(3) = 4.672, p
= 0.014] and a significant effect of dose during the chronic condition [F(4) = 3.937, p = 0.014].
Pairwise comparisons indicated that 0.3 mg/kg nicotine significantly decreased IPs [t(6) =
3.764, p = 0.009], relative to saline during the acute condition. Additionally, 1.7 mg/kg nicotine
significantly decreased IPs [t(6) = 4.789, p = 0.003], relative to saline during the chronic
condition. Lower IPs are associated with more risky choice. See Table 6 for IPs at each dose and
condition for individual rats.
Discounting Rate (h)
Figure 10 shows mean h as a function of each dose of nicotine during acute and chronic
drug exposure. There was a significant effect of dose during the acute condition [F(3) = 6.125, p
= 0.005] and a significant effect of dose during the chronic condition [F(4) = 3.930, p = 0.014].
Pairwise comparisons indicated that 0.3 mg/kg nicotine significantly decreased h [t(6) =
3.764, p = 0.009], and 1.0 mg/kg nicotine significantly decreased h [t(6) = -4.389, p = 0.005],
relative to saline during the acute condition. Only 1.7 mg/kg nicotine significantly decreased h
[t(6) = -4.789, p = 0.003], relative to saline during the chronic condition. Smaller h values
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indicate higher levels of risky choice. See Table 6 for h levels at each dose and condition for
individual rats.
Win-Stay and Lose-Shift Ratios
Figure 11 shows mean win-stay and lose-shift ratios as a function of each dose of
nicotine during acute and chronic drug exposure. There was a significant effect of dose on winstay ratios during the chronic condition [F(4) = 3.713, p = 0.017]. Pairwise comparisons
indicated that 0.1 mg/kg nicotine significantly increased win-stay ratios [t(6) = -3.927, p =
0.008], relative to saline during the chronic condition. There were no other significant effects on
win-stay and lose-shift measures. Larger win-stay ratios indicate higher reinforcer sensitivity
while larger lose-shift ratios indicate higher loss aversion. See Table 7 for win-stay and lose-shift
ratios at each dose and condition for individual rats.
Discussion
The present study was designed to assess effects of acute and chronic nicotine
administration on risky decision-making in a probability-discounting procedure. Largerreinforcer choice systematically declined as a function of decreasing probabilities of delivery
during all conditions, indicating that choice was sensitive to the programmed contingencies of
the procedure. Similar to the results found by Mendez et al. (2012), acute nicotine administration
dose-dependently increased risky choice as demonstrated by percent larger-reinforcer choice,
AUC, IP, and h measures. Repeated nicotine administration resulted in habituation to nicotine’s
effects on risky choice, as seen in the first five sessions of repeated 1.0 mg/kg nicotine exposure.
Higher doses of nicotine were required to increase larger-reinforcer choice during the
redetermination of the dose-effect function, shifting it to the right, which indicates tolerance to
nicotine’s effects on risky choice.
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Other preclinical research suggests tolerance can develop to certain effects of nicotine
(e.g., Anderson & Diller, 2010; Semenova et al., 2007; Stolerman et al., 1973; Stolerman et al.,
1974). Anderson and Diller (2010) demonstrated tolerance using a within-session delaydiscounting procedure that shares many similarities to the probability-discounting procedure
used in the current study. Across these two studies, acute nicotine administration decreased
impulsive choice, but increased risky choice, but repeated 1.0 mg/kg nicotine resulted in a return
to baseline levels of choice in both experiments. The current study highlights that procedural
similarities between delay-discounting and probability-discounting procedures can lend to
helpful comparisons of pharmacological manipulations. In this case, these direct comparisons
indicate that tolerance may develop to nicotine’s effects on multiple types of maladaptive
decision-making, whether these decisions involve impulsive or risky choices (though see Dallery
& Locey, 2005).
Risky Choice and Tolerance in Smokers
Within human research, probability discounting among smokers shows mixed results.
Multiple studies suggest smokers significantly discount the value of delayed monetary outcomes,
but not probabilistic monetary outcomes, when compared to nonsmokers (Białaszek et al., 2017;
Mitchell, 1999; Ohmura et al., 2005), though the insignificant differences in probability
discounting between smokers and nonsmokers may be due to floor effects (e.g., Yi et al., 2007).
However, when assessing a wide range of commodities, such as cigarettes, monetary outcomes,
and health outcomes, smokers made significantly more risky choices compared to nonsmokers
(Poltavski & Weatherly, 2013; also see Reynolds et al., 2004). These tasks may be difficult to
interpret since the majority of choices provided in human discounting procedures are
hypothetical, and discounting rates during hypothetical conditions may conflict with discounting
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rates of real or potentially real rewards during experimental sessions (Green & Lawyer, 2014;
Robertson & Rasmussen, 2018; though see Hinvest & Anderson, 2010). Research using the
Balloon Analogue Risk Task (a procedure that assesses choice between a smaller, less risky
option and a larger option associated with an increasing risk of loss) found higher doses of
nicotine decreased risk-taking, but this effect was only observed in male participants (i.e., a sexdependent effect; Pilarski et al., 2014).
To date, no studies have assessed tolerance to nicotine’s effects on risky choice and
probability discounting in human samples, but other measures have been evaluated. Some
research suggests tolerance to subjective effects of nicotine exposure are likely to develop after
repeated administration. These subjective effects are mostly obtained through self-report.
Following acute nicotine administration, nonsmokers are more likely to report subjective effects
such as increased fatigue, tension, and confusion when compared to smokers (i.e., smokers
generally showed reduced responding to these subjective effects; Perkins et al., 1994; Perkins,
2002). In contrast, acute nicotine administration is associated with increased rates of fine-motor
movements (e.g., finger-tapping), improved speed on certain procedures such as the Stroop task,
and increases in heart rate, but smokers and nonsmokers display similar levels on these
measures, indicating repeated nicotine exposure results in little to no tolerance on these effects
(Perkins et al., 1994; Perkins, 2002). This research indicates that tolerance to nicotine’s effects
may be observed for some responses but not others, and these effects will not generalize across
responses (i.e., drugs can have multiple effects).
The current study may have implications for new smokers. It seems nicotine may cause
an increase in risky choice, but this is more likely to happen under acute conditions. In a study
using human participants, adolescents who recently took up smoking made significantly more
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risky choices when compared to never smokers and current smokers, and no other group
differences in probability discounting were observed (Reynolds et al., 2003). Based off these
findings and the current study, increases in risky choice due to nicotine administration may be a
relatively transient outcome once repeated administrations take effect. Risky choice may be more
likely to maintain if smokers continue to increase their levels of nicotine consumption.
Pharmacological and Behavioral Mechanisms of Tolerance to Nicotine’s Effects on Choice
The current study indicates that cholinergic transmission is involved in risky decisionmaking. Activation of nAChRs results in the downstream release of various neurotransmitters,
including acetylcholine, DA, glutamate, γ-aminobutyric acid, and serotonin (Benowitz, 2009;
Markou, 2008). Nicotine-induced DA release may be partly responsible for nicotine’s increased
effects on risky choice, since increased DA transmission results in increased risky choice on the
rat gambling task and probability-discounting procedure (e.g., Di Ciano & Le Foll, 2018; Jenni et
al., 2017; St. Onge & Floresco, 2009).
The continued presence of nicotine may result in changes in nAChRs number and affinity
(i.e., neuroadaptation). Desensitization of nAChRs, particularly α4β2 receptors, has been
observed with long-term exposure to nicotine (Benowitz, 2010). The desensitized post-synaptic
neuron requires higher doses of nicotine to obtain the same drug effect observed during acute
administration (i.e., tolerance; Govind et al., 2009). Upregulation of receptors also occurs with
chronic nicotine exposure and is thought to be partly a response to nicotine-mediated
desensitization of nAChRs (e.g., Marks et al., 1983; Marks & Collins, 1985; see Govind et al.,
2009 for a review). Upregulation of receptors is characterized by an increase in receptors or
effects of receptor activation. nAChRs upregulation may result in increased DA release in the
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shell of the nucleus accumbens due to nicotine’s increased effects on dopaminergic neurons in
the ventral tegmental area (Benowitz, 2010; Govind et al., 2009).
The current study demonstrated acute nicotine administration dose-dependently increased
risky choice (i.e., significantly influenced percent larger-reinforcer choice, AUC, IP, and h
measures) but had little effect on win-stay and lose-shift ratios. Due to these results, nicotine
likely increases risky choice through other behavioral mechanisms not related to reinforcer or
loss sensitivity. Previous research indicates that nicotine disrupts sensitivity to reinforcer
magnitude, and may decrease the value of a large reinforcer, relative to a small reinforcer (Locey
& Dallery, 2009; Locey & Dallery, 2011). Other disruptions, such as decreased sensitivity to
larger-reinforcer probabilities of delivery, may also account for the observed increases in risky
choice. Repeated administration resulted in a return to baseline levels of choice, so repeated
nicotine exposure may attenuate disruptions in sensitivity to reinforcer magnitude and
probabilities of delivery, perhaps to correct for reinforcement loss experienced during acute
nicotine administrations (see Schuster et al., 1966).
Limitations and Future Directions
There were some limitations to the present study. Several measures, including percent
larger-reinforcer choice, were used because of their comparisons to measures in delaydiscounting procedures. Within the probability-discounting procedure, choice for the larger,
uncertain reinforcer was advantageous in the first two session blocks, and disadvantageous in the
last three blocks. In delay discounting, it is advantageous to choose the larger, later reinforcer,
and disadvantageous to choose the smaller, sooner reinforcer across all session blocks. So,
changes in percent larger-reinforcer choice in delay-discounting procedures always indicate
changes in maladaptive choice, but similar changes in probability-discounting procedures only
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reflect changes in maladaptive choice when the probability of larger-reinforcer delivery is
relatively low. Thus, other measures based on whole-session responding (AUC, IPs, h values)
may not be as sensitive to risky choice compared to block-by-block measures.
Future research could investigate how different procedural manipulations within the
probability-discounting procedure affect risky choice. For example, previous studies using
probability-discounting procedures have utilized several series of larger-reinforcer probabilities
(e.g., 100/50/25/12.5/6.25%, 100/66.7/33.3/16.7/8.3%; see Cardinal & Howes, 2005; Ozga-Hess
& Anderson, 2019). Future research could include ranges in which larger-reinforcer choice is
suboptimal (or optimal) across most blocks. Other variables, such as reinforcer magnitude, could
also be manipulated. Also, one study found that a descending probability schedule increased
risky choice relative to an ascending schedule (Yates et al., 2016). Manipulating these procedural
variables may affect risky choice, as well as drug effects on these responses.
Additionally, the present study was limited to the use of male Sprague-Dawley rats as
subjects. Some preclinical research suggests some delay discounting and probability discounting
effects may be sex-dependent (e.g., Eubig et al., 2014; Íbias & Nazarian, 2020; Smethells et al.,
2016). For example, in a study by Islas-Preciado et al. (2020), male rats were more likely to
make risky choices on a probability discounting task during baseline conditions, compared to
female rats. 0.5 mg/kg amphetamine increased risky choice in both male and female rats, but
male rats still showed higher levels of risky choice. In another study, Ozga-Hess and Anderson
(2019) evaluated effects of d-amphetamine and atomoxetine on risky choice in LEW and F344
rats. These strains are known to have neurochemical and behavioral differences, with LEW
engaging in higher levels of impulsive choice on delay-discounting tasks compared to F344 (e.g.,
Anderson & Woolverton, 2005; Anderson & Diller, 2010; Huskinson & Anderson, 2012). LEW
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and F344 did not differ in risky choice at baseline, and d-amphetamine and atomoxetine had
similar effects on risky behavior, indicating biological variations between the two strains may
differentially impact certain types of decision-making, and these effects don’t generalize. Future
research could investigate possible sex and/or strain differences in nicotine’s effects on risky
choice.
Another area of research is to investigate how baseline-dependent responding affects the
interaction between probability discounting and drug effects. Some research indicates nicotine’s
effects on impulsive choice may be baseline dependent (Kayir et al., 2014; Kolokotroni et al.,
2014). Studying baseline-dependent responding in future research could be accomplished by
employing strains known to exhibit differences in choice levels or assigning animals to
conditions based on their natural baseline behavior. Future research could also further
manipulate cholinergic transmission by administering AChR antagonists, such as mecamylamine
and scopolamine, prior to nicotine administration. Effects of specific nAChRs subunits could
also be investigated to better elucidate effects of nicotine and the role of cholinergic transmission
in risky choice.
Summary and Conclusions
In summary, acute nicotine administration dose-dependently increased risky choice and
repeated administration resulted in a return to baseline levels of choice (i.e., tolerance). This
work supports the role of cholinergic transmission in risky choice. Further work should address
how procedural manipulations (i.e., probability ranges, reinforcer magnitude, order of probability
presentation), sex differences, strain differences, and baseline-dependent responding influence
risky choice and nicotine’s effects on this type of decision-making. Further research is necessary
to better understand how nicotine affects choice behavior.
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Figure 1
Mean Percent Larger-Reinforcer Choice as a Function of Probability of Delivery During the
Last Five Sessions of Baseline (N = 8)

Note. Error bars indicate the standard error of the mean.

57

NICOTINE AND CHOICE OF PROBABILISTIC OUTCOMES

58

Figure 2
Mean Percent Larger-Reinforcer Choice as a Function of Probability of Delivery During Acute
Drug Exposure (N = 7)

*
*

*

Note. “SAL” corresponds to saline vehicle and error bars represent standard error of the mean.
Asterisks represent a statistically significant difference from saline vehicle (p < .05). Higher
levels of percent larger-reinforcer choice indicate more risky choice.
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Figure 3
Individual Means for Percent Larger-Reinforcer Choice as a Function of Probability of Delivery
During Acute Drug Exposure

Note. “SAL” corresponds to saline vehicle and error bars represent standard error of the mean.
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Figure 4
Mean AUC for Saline, Acute 1.0 mg/kg NIC, and the First Five Days of Chronic 1.0 mg/kg NIC
Drug Exposure (N = 7)
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Note. “AUC” corresponds to area under the curve. “SAL” corresponds to saline vehicle and
“1.0” corresponds to acute 1.0 mg/kg NIC exposure. Error bars represent standard error of the
mean. Asterisks represent a statistically significant difference from Day 1 values, and number
signs indicate a statistically significant difference from acute 1.0 mg/kg NIC (p < .05). Larger
AUC levels indicate more risky choice.
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Figure 5
Mean Percent Larger-Reinforcer Choice as a Function of Probability of Delivery During
Chronic Drug Exposure (N = 7)

*

*

Note. “SAL” corresponds to saline vehicle and error bars represent standard error of the mean.
Asterisks represent a statistically significant difference from saline vehicle (p < .05). Higher
levels of percent larger-reinforcer choice indicate more risky choice.
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Figure 6
Individual Means for Percent Larger-Reinforcer Choice as a Function of Probability of Delivery
During Chronic Drug Exposure

Note. “SAL” corresponds to saline vehicle and error bars represent standard error of the mean.
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Figure 7
Mean Percent Larger-Reinforcer Choice Across the Last Three Blocks as a Function of Dose
During Acute and Chronic Conditions (N = 7)
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*

Note. “SAL” corresponds to saline vehicle and error bars represent standard error of the mean.
Asterisks represent a statistically significant difference from saline vehicle (p < .01). Higher
levels of percent larger-reinforcer choice indicate more risky choice.
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Figure 8
Mean AUC as a Function of Dose During Acute and Chronic Conditions (N = 7)

*
*

*

Note. “AUC” corresponds to area under the curve. “SAL” corresponds to saline vehicle and error
bars represent standard error of the mean. Asterisks represent a statistically significant difference
from saline vehicle (p < .01). Larger AUC levels indicate more risky choice.
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Figure 9
Mean IPs as a Function of Dose During Acute and Chronic Conditions (N = 7)

*

**

Note. “IPs” corresponds to indifference points. “SAL” corresponds to saline vehicle and error
bars represent standard error of the mean. Asterisks represent a statistically significant difference
from saline vehicle. IPs reflect indifference to probability of larger-reinforcer delivery, so lower
IPs are associated with more risky choice.
*p < .05. **p < .01.
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Figure 10
Mean Discounting Rate (h) as a Function of Dose During Acute and Chronic Conditions (N = 7)

**

**
*

Note. “SAL” corresponds to saline vehicle and error bars represent standard error of the mean.
Asterisks represent a statistically significant difference from saline vehicle. Smaller h values
indicate higher levels of risky choice.
*p < .05. **p < .01.
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Figure 11
Win-Stay/Lose-Shift Ratios as a Function of Dose During Acute and Chronic Conditions (N = 7)

*

Note. “SAL” corresponds to saline vehicle and error bars represent standard error of the mean.
Asterisks represent a statistically significant difference from saline vehicle (p < .05). Larger winstay ratios indicate higher reinforcer sensitivity while larger lose-shift ratios indicate higher loss
aversion.
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Figure 12
Mean Percent Larger-Reinforcer Choice Under Saline as a Function of Probability of Delivery
During Acute and Chronic Conditions (N = 7)

Note. “SAL” corresponds to saline vehicle and error bars indicate the standard error of the mean.

